This article is more than 5 years old. Information may no longer be current.
FDA approves cardiac device manager with iPad capabilities
Click Here to Manage Email Alerts
Medtronic announced that its device manager for implanted cardiac devices has been approved by the FDA.
This next-generation device manager (CareLink SmartSync) is an update to a previous programmer (CareLink 2090), according to a press release from the company.
The updated programmer and pacing system analyzer can be used in conjunction with an iPad (Apple) to manage data and program implanted cardiac devices with the ability to communicate wirelessly (BlueSync). It also has a simplified user interface, Bluetooth capabilities to sync with compatible cardiac devices and enhanced security features such as run time application monitoring, multi-encryption and access restrictions.
The system is portable, weighing a little more than 2 lb, and includes other features such as a mobile application, telemetry head and pacing system analyzer, according to the release.
“Clinicians will benefit from the portability that SmartSync offers, and because it was built to replicate the familiar CareLink 2090 interface, the transition to this new technology is quite simple,” Rob Kowal, MD, PhD, chief medical officer and vice president of medical affairs and business development of the cardiac rhythm and heart failure division at Medtronic, said in the release.
Disclosure : Kowal is an employee of Medtronic.